Urogen Pharma Ltd.
URGN
Revenue
37.84M
▲10.36M▲37.68%
3 Months ChangeAssets
200.46M
▲15.41M▲8.33%
3 Months ChangeLiabilities
305.93M
▲5.48M▲1.82%
3 Months ChangeFree Cash Flow
-42.07M
▼-10.33M▼-32.56%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001437749-26-006233
2026-03-02
Form 8-K
ID: 0001193125-26-084282
2025-11-06
Form 10-Q
ID: 0001437749-25-033468
2025-11-06
Form 8-K
ID: 0001437749-25-033466
2025-08-27
Form 8-K
ID: 0001437749-25-027874
2025-08-07
Form 10-Q
ID: 0001437749-25-025243
2025-08-07
Form 8-K
ID: 0001437749-25-025242
2025-07-03
Form 8-K
ID: 0001193125-25-155503
2025-06-13
Form 8-K
ID: 0001193125-25-140339
2025-05-12
Form 10-Q
ID: 0001437749-25-015956